Ten veterinary pathologists independently assigned histologic grades to the same 60 canine cutaneous mast cell tumors using the Patnaik classifications. The degree of agreement in grading among the pathologists was compared with the degree of agreement among the same pathologists in a previous study, in which each pathologist used the reference for grading that he/she uses routinely. Mean agreement improved significantly from 50.3% to 62.1% with uniform use of the Patnaik classifications (P ϭ 0.00001), suggesting that there is value in uniform application of a single grading scheme for canine cutaneous mast cell tumors. Agreement among pathologists was still not 100%, suggesting that a more objective grading scheme should be developed and that other histologic indicators of prognosis should be investigated.
Mast cell tumors (MCTs) are the most common cutaneous tumors of the dog. 13 These tumors vary widely in their behavior, from nearly benign to highly invasive and metastatic. It has been recognized for more than 30 years that histologic grading is prognostic for the behavior of canine cutaneous MCTs. 3, 6, 10 The 2 most widely recognized grading systems classify MCTs into 3 grades based on histologic characteristics, including cellularity, cell morphology, invasiveness, mitotic activity, and stromal reaction. 3, 10 Both grading systems correlate with the survival rate of canine patients with MCTs and histologic grade is the most important factor in determining the staging tests and adjunctive therapy that will be recommended for a dog with a cutaneous MCT. 9, 13 Because of the importance of histologic grade in prognosis and decision making in the therapeutic management of dogs with MCTs, it is essential that veterinarians understand the variability among pathologists in assigning grades to MCTs. In a previous study, it was demonstrated that there was significant variation in the histologic grades assigned to the same 60 canine cutaneous MCTs by 10 veterinary pathologists at 1 institution. 8 Because variation in histologic grading was significantly associated with the use of different references describing grading systems, it was hypothesized that if all pathologists utilized the same reference for grading, there would be improved agreement in the grades as-signed to canine cutaneous MCTs. The objective of this study was to determine whether variation among veterinary pathologists in the histologic grading of canine cutaneous MCTs could be eliminated by uniform use of a single grading scheme.
Ten veterinary pathologists independently graded the same 60 canine cutaneous MCTs as grade I, II, or III using the Patnaik classifications (Table 1) . 10 These were the same 10 veterinary pathologists who participated in the previous study to evaluate variation among pathologists in histologic grading of canine cutaneous MCTs. 8 Four of these pathologists were from the University of Georgia College of Veterinary Medicine (UGA-CVM) Department of Pathology, 5 were from the UGA Athens Veterinary Diagnostic Laboratory (also located at the UGA-CVM), and 1 pathologist had recently moved from the UGA-CVM Department of Pathology to Emory University Yerkes National Primate Research Center.
The University of Georgia College of Veterinary Medicine (UGA-CVM) patient database was searched to identify dogs diagnosed with cutaneous MCT from 1995 to 2002. Histology reports were reviewed to identify 20 cutaneous MCTs each originally reported as low, intermediate, and high histologic grade, for a total of 60 tumors. The first 20 MCTs identified for each grade were chosen for this study and recut sections from banked blocks were obtained from each MCT for hematoxylin and eosin staining. These were the same slides used in the initial study of variation in MCT grading; however, they were presented in a newly randomized order provided by the UGA Statistical Consulting Service and more than 2 years had passed since the pathologists had originally evaluated the slides.
Slides were reviewed prior to randomization by 1 pathologist (E.W.H.) to confirm diagnosis and adequacy of sections and staining for evaluation. Pathologists were blinded to pa- tient identity, previously reported tumor grade, and percentages of MCTs assigned each grade previously. No information regarding patient history, tumor size, or tumor site was provided with the slides. Pathologists were instructed to independently evaluate the slides in the order provided using the Patnaik classifications 10 and each pathologist was provided a copy of the Patnaik reference. Two weeks were allowed for each pathologist to grade the MCTs. Statistical analysis of data was performed using Light's weighted kappa () statistic 4 for agreement among observers. This test compares the agreement of the MCT grades given to each tumor by 2 pathologists and assigns a value from Ϫ1.0 to 1.0 that describes the degree of agreement or disagreement on the grades of all of the MCTs for each pair of pathologists. In addition, this test takes into account the degree of disagreement (for example, there is more disagreement when the same tumor is assigned grades of I and III by 2 pathologists than when grades I and II are assigned to the same tumor). A value of 1.0 indicates agreement on the grade of all of the tumors, Ϫ1.0 indicates disagreement on the grade of all of the tumors, and 0.0 indicates that agreement is random. As measures of agreement, values are interpreted as follows: Յ0.20, poor; 0.21-0.40, fair; 0.41-0.60, moderate; 0.61-0.80, substantial; and Ͼ0.80, good. This test was used to compare all pairwise combinations of the 10 pathologists. A paired t-test was used to compare the mean Light's weighted value from the first study, when each pathologist used the reference for grading that he/she uses routinely for clinical cases, to the mean Light's weighted value from the second study, when all pathologists used the Patnaik classifications. Significance was set at a P value less than 0.05. SAS software a was used to perform the statistical analyses.
The most commonly assigned grade was grade I for 6 MCTs, grade II for 36 MCTs, and grade III for 18 MCTs. There was agreement among all 10 pathologists on the grade of 16 of 60 tumors, compared with all 10 pathologists agreeing on only 4 of 60 tumors in the first study. 8 Three MCTs were assigned all 3 grades. These were different tumors from the 6 (of 60) MCTs assigned all 3 grades in the first study. Agreement among pathologists in grading the MCTs using the Patnaik classifications 10 and in the previous study (when each pathologist used the grading classification reference that he/she uses routinely) is presented in Fig. 1 .
In comparing the grades assigned to the MCTs, for 31 of 45 possible combinations of the 10 pathologists, agreement was improved with uniform use of the Patnaik classifications, 10 and for 14 of 45 combinations, there was less agreement. Based on the Light's weighted kappa statistic for each study, the mean agreement of all 45 combinations of the 10 pathologists increased from 50.3% (Light's weighted kappa ϭ 0.503 Ϯ 0.027 standard error of the mean) in the previous study to 62.1% (Light's weighted kappa ϭ 0.621 Ϯ 0.022 standard error of the mean) with uniform use of the Patnaik classifications. This increase was statistically significant, P ϭ 0.00001.
The percentage of MCTs assigned each histologic grade by each pathologist is presented in Table 2 . The percentage of MCTs for which each pathologist agreed with the most commonly assigned grade is also presented in Table 2 . Eight of the 10 pathologists agreed with the most commonly assigned grade for Ͼ80% of the MCTs.
The results of this study demonstrate that uniform application of a single reference for the histologic grading of canine cutaneous MCTs significantly decreases, but does not eliminate, variation among veterinary pathologists in grading MCTs. A mean agreement of 62.1% (mean kappa ϭ 0.621) among 10 pathologists in grading the same MCTs with uniform use of a single grading scheme represents substantial agreement, but is still not 100%. As one would expect, the majority of disagreement was between grades I and II or grades II and III. Having grades I and III assigned to the same tumor is unexpected and is of concern due to the significant difference in associated prognoses. For the 3 MCTs assigned all 3 grades, there were 2 grades that predominated and a third grade assigned by only 1 pathologist. Because these were not the same MCTs assigned all 3 grades in the previous study, it is possible that this variation may represent errors in recording the tumor grade in the data table provided to the pathologists for this study or perhaps an issue of the consistency of an individual pathologist in grading MCTs. Table 2 was included to show the percentage of MCTs classified as each grade and to give an indication of how often each pathologist agreed with the most commonly assigned grade for the MCTs. Because there is no gold standard for determining the correct grade for MCTs, the information in this table does not demonstrate which pathologist was most often correct in grading; it is just an indicator of agreement with the consensus grade of the tumors. It is important to note that all of the pathologists that participated in this study worked at a single institution during the initial study and 1 had only recently moved for the current study. Consequently, it would be expected that there would be better agreement among pathologists in the initial study and that this might have decreased the amount of improvement possible in the current study. It is also possible that inclusion of only pathologists at a single institution may have in-creased the improvement in grading consensus in this study if it resulted in increased willingness of the pathologists to accept and apply a standard grading scheme.
Possible explanations for the observed variation in grading might include subjectivity in the grade classifications, difficulty determining or distinguishing between some characteristics in the grade classifications, or heterogeneity in the histologic appearance of different areas of a single MCT. In addition, it is possible that there may be reluctance by some pathologists to upgrade a tumor based on a single cell or small area with higher grade morphology or a tendency by some pathologists, over the course of 60 tumors, to inadvertently revert to using of the grading scheme they use routinely rather than continuing to follow the Patnaik classifications. Another possible limitation to the level of agreement, not evaluated in this study, would be intraobserver variation in grading the tumors. A uniformly applied histologic grading system with improved reproducibility is desirable for canine cutaneous MCTs, but complete agreement among pathologists, particularly on intermediate-grade tumors, may not be a realistic expectation for any grading system.
Interobserver variation in histologic grading is not unique to canine cutaneous MCTs or to veterinary pathology. There have been several studies evaluating interobserver variability of histologic grading systems for a variety of human cancers. 1, 2, 5, 11, 12 Studies of the reproducibility of tumor grading among surgical pathologists evaluating human endometrial carcinomas, renal cell carcinomas, breast cancers, and salivary mucoepidermoid cancers, for example, have revealed results that are similar to, or worse than, what was observed in the current study, with mean values of 0.29-0.69. 1, 2, 5, 11, 12 Similar to the study presented here, these studies reflect the interest of human pathologists and oncologists to better understand the variability in existing grading systems and direct efforts toward developing grading systems for cancer that might offer greater reproducibility and prognostic power.
Because of the inherent subjectivity and variation in histologic grading of MCTs, other histologic information and molecular markers that might serve as prognostic indicators should be developed and investigated for relationship to response to treatment, tumor control, and survival. Proliferation markers, staining for abnormal growth factor receptor expression, staining for abnormal tumor suppressor gene expression, and staining for hormone receptor expression are examples of histologic prognostic indicators that have been evaluated in veterinary pathology. Recently, investigators have reported the prognostic significance of a new classification system for canine cutaneous MCTs based on the pattern of KIT receptor tyrosine kinase immunohistochemical staining in tumor cells. 7 Increased cytoplasmic KIT staining was significantly associated with an increased rate of local recurrence and a decreased survival rate. Continued development and application of innovative special histologic procedures like KIT immunohistochemical staining will likely complement histologic grading and improve the ability of veterinary clinicians to provide accurate prognoses and appropriate therapies for companion animals with cancer.
In conclusion, uniform application of a single grading sys-tem improved but did not eliminate variation in the histologic grading of canine cutaneous MCTs. Despite its limitations, histologic grade remains a key prognostic indicator for dogs with cutaneous MCTs. In light of the variability in grading observed in this study, it is important for clinicians to be aware that variation in histologic grading of MCTs exists and to consider this variation and other known prognostic indicators together with the grade when planning treatment for dogs with cutaneous MCTs. A uniformly accepted, more reproducible grading system is needed, and other histologic prognostic indicators should continue to be investigated.
